Missing Microbes in Infants Born by Cesarean Section (MiMIC)
Missing Microbes in Infants Born by Caesarean Section: Antenatal Antibiotics and Mode of Delivery
Sponsor: Dupont Applied Biosciences
This observational or N/A phase trial investigates C Section and is currently ongoing. Dupont Applied Biosciences leads this study, which shows 9 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
9 versions recorded-
Feb 2026 — Present [monthly]
Unknown
Status: Recruiting → Unknown
-
Sep 2024 — Feb 2026 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Feb 2024 — Jul 2024 [monthly]
Recruiting
-
Mar 2023 — Feb 2024 [monthly]
Recruiting
▶ Show 4 earlier versions
-
Dec 2021 — Mar 2023 [monthly]
Recruiting
-
Jan 2021 — Dec 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Nov 2019 — Nov 2020 [monthly]
Recruiting
First recorded
Jul 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Dupont Applied Biosciences
- University College Cork
For direct contact, visit the study record on ClinicalTrials.gov .